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Abstract. Four known polyhydroxypregnane glycosides, dregeoside Da1 (1), volubiloside A (2), 
drevoluoside N (3), and volubiloside C (4) were isolated from the methanol extract of the leaves 
of Dregea volubilis (L.f.) Benth. ex Hook. f. Their structures were elucidated by 1D-, 2D-NMR, 
spectra and compared with those reported in the literature. At concentration of 30 µM, 
compounds 1-4 did not exhibit cytotoxic activity against human colorectal adenocarcinoma cells 
(HT-29) with cell viability percentages ranging from 100.83 ± 1.50% to 105.45 ± 1.57% versus 
control. This is a new contribution to phytochemical study of D. volubilis in Viet Nam.    
Keywords: Dregea volubilis, Apocynaceae, polyhydroxypregnane glycoside. 
Classification numbers: 1.1.1, 1.2.1. 
1. INTRODUCTION 
Dregea volubilis (L.f.) Benth. ex Hook. f. (Apocynaceae) is a woody climbing plant that can 
be up to 12 m tall. It is used for treating inflammation, rheumatic pain, fever, cough, and severe 
cold [1]. Phytochemical screening indicated ethanol and water extracts of D. volubilis leaves 
having antibacterial activity against several microorganism such as Bacillus subtilis, 
Staphylococcus aureus, S. warneri, Acinetobacter baumannii, Escherichia coli, Klebsiella 
pneumoniae, Proteus mirabilis, Pseudomonas putida, and P. aeruginosa [2]. Ethanol extract of D. 
volubilis flowers has remarkable inhibitory effects on α-glucosidase and α-amylase activities [3]. 
At both oral doses of 100 and 200 mg/kgP/day during 15 days of treatment, petroleum ether extract 
of D. volubilis fruits dose dependently normalized blood glucose levels in streptozotocin induced 
hyperglycemic rats [4]. The chemical constituents of this plant have been then studied and showed 
to contain a lot of polyhydroxypregnanes and polyhydroxypregnane glycosides [5, 6], pentacyclic 
triterpenes [7], and flavonoids [8]. In our previous study, three new pregnane glycosides from the 
leaves of D. volubilis and their α-glucosidase inhibitory activity were reported [9]. Chemical 
structure of pregnane glycosides from D. volubilis contained interesting sugar units such as 6-
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deoxy-3-O-methyl-D-allose, D-cymarose, D-digitoxose, and D-oleandrose which are rarely found 
in natural occurring compounds [5, 6]. In this paper, we continue to report detailed structural 
elucidation of four known polyhydroxypregnane-type glycosides from the leaves of D. volubilis. 
The cytotoxic activity of isolated compounds on human colorectal adenocarcinoma cells (HT-29) 
were also evaluated by MTS assay.  
2. MATERIALS AND METHODS 
2.1. Plant materials 
The Dregea volubilis (L.f.) Benth. ex Hook. f. leaves were collected at Lang Son, Viet 
Nam in September 2017 and identified by Dr. Nguyen The Cuong, Institute of Ecology and 
Biological Resources, VAST. A voucher specimen (NCCT-P75) was deposited at the Institute 
of Marine Biochemistry, VAST. 
2.2. General experimental procedures 
All NMR spectra were recorded on a Bruker 500 MHz. HPLC was carried out using an 
AGILENT 1100 HPLC system. Column chromatography (CC) was performed on silica-gel 
(Kieselgel 60, 230-400 mesh, Merck) or RP-18 resins (30 - 50 μm, Fuji Silysia Chemical Ltd.). 
2.3. Extraction and isolation 
The dried leaves of D. volubilis (5.0 kg) were sonicated with hot methanol then removed 
from solvent to yield solid extract (630 g). The extract was suspended in water and successively 
partitioned with n-hexane, and dichloromethane to give n-hexane (DV1, 90 g) and 
dichloromethane (DV2, 200 g) fraction and water layer. DV2 was chromatographed on a silica 
gel column eluting with n-hexane:acetone (100:0 → 0:1, v/v) to give fractions (DV2A-DV2F). 
DV2D was chromatographed on a RP-18 column eluting with methanol:water (2:1, v/v) to give 
smaller fractions (DV2D1-DV2D6). DV2D1 was chromatographed on a RP-18 column eluting 
with acetone:water (1.2:1, v/v) to give smaller fractions (DV2D1A and DV2D1B). Compound 1 
(88.4 mg) was obtained from DV2D1B fraction on HPLC J’sphere ODS M-80 column (150 mm 
length×20 mm ID), 35 % ACN in H2O, and a flow rate of 3 mL/min. DV2F was 
chromatographed on a RP-18 column eluting with acetone:water (1:1.8, v/v) to give smaller 
fractions (DV2F1-DV2F3). DV2F1 was chromatographed on a RP-18 column eluting with 
methanol:water (1:1, v/v) to give fractions (DV2F1A and DV2F1B). Compounds 2 (151.0 mg) 
and 3 (7.3 mg) were obtained from DV2F1B on HPLC column using J’sphere ODS M-80 (150 
mm length×20 mm ID), 24 % ACN in H2O, and a flow rate of 3 mL/min. DV2F3 was 
chromatographed on a RP-18 column eluting with methanol:water (1:1, v/v) to give two 
fractions (DV2F3A and DV2F3B). Compound 4 (24.0 mg) was obtained from DV2F3B by 
chromatography on HPLC using J’sphere ODS M-80 column (150 mm length ×20 mm ID), 
eluting with 24 % ACN in H2O and a flow rate of 3 mL/min. 
Dregeoside Da1 (1): White amorphous powder;  +10.5 (c 0.1, MeOH); MF 
C42H70O15; HR-ESI-MS: m/z 859.4680 [M+HCOO]¯ (calcd for C43H71O17, 859.4691); 
1
H- and 
13
C-NMR (CD3OD): see Table 1. 
Volubiloside A (2): White amorphous powder;  15.7 (c 0.1, MeOH); MF C48H80O20; 
HR-ESI-MS: m/z 1021.5191 [M+HCOO]¯ (calcd for C49H81O22, 1021.5219); 
1
H- and 
13
C-NMR 
(CD3OD): see Table 1. 
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Drevoluoside N (3): White amorphous powder;  +21.6 (c 0.1, MeOH); MF 
C48H80O21; HR-ESI-MS: m/z 993.5248 [M+H]
+
 (calcd for C48H81O21, 993.5270); 
1
H- and 
13
C-
NMR (CD3OD): see Table 2. 
Volubiloside C (4): White amorphous powder;  +24.4 (c 0.1, MeOH); MF C48H78O20; 
HR-ESI-MS: 973.5022 [M-H]¯ (calcd for C48H77O20, 973.5008); 
1
H- and 
13
C-NMR (CD3OD): 
see Table 2. 
2.4. Cytotoxic evaluation 
HT29 cells were cultured in supplemented RPMI 1640 medium containing 10 % fetal 
bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin. The cells were seeded in a 96 
well plate and incubated at 37 °C in humidified atmosphere (95 % air and 5  CO2). After 24 h of 
incubation, the cells were treated with/without the compounds (final concentration of 30 µM) 
and incubated for additional 48 h. Culture medium was carefully removed and MTS solution 
was added for reaction in 1 h. The produced formazan by cellular reduction of MTS was 
quantified by measuring the absorbance at 490 nm with an Infinite M200 microplate reader 
(Tecan, Grodig, Austria). MTS assay was conducted using CellTiter 96 aqueous one solution 
cell proliferation assay kit (Promega, Madison, WI, USA). Experiments were performed in 
triplicate. Cell viability is expressed as the percentage of absorbance in sample wells compared 
to the vehicle. 
3. RESULTS AND DISCUSSION 
The dried powder of D. volubilis was extracted with methanol. Crude extract was then 
fractionated into low-polarity, mid-polarity, and high polarity fractions by successive separation 
with n-hexane and dichloromethane. Low-polarity fraction (n-hexane extract) contained oil and 
fatty compounds which were not subjected to chemical studies. After TLC analysis, 
dichloromethane extract was firstly selected for purification of compounds. Using combination 
of chromatographic methods, four compounds 1-4 were isolated from dichloromethane extract 
of D. volubilis leaves. 
 
 
Figure 1. Chemical structures of compounds 1-4.  
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Table 1. 
1
H- and 
13
C-NMR spectroscopic data for compounds 1 and 2 in CD3OD. 
C   1   2 
δC
# δC δH (mult, J in Hz) δC
$ δC δH (mult, J in Hz) 
1 39.7 40.2 1.13 (m)/2.68 (m) 39.8 40.2 1.14 (m)/2.68 (m) 
2 30.6 30.8 1.58 (m)/1.84(m) 3.6 30.8 1.58 (m)/1.83 (m) 
3 78.0 79.3 3.50 (m) 77.8 79.2 3.50 (m) 
4 40.0 40.3 2.20 (m)/2.35 (m) 39.4 40.3 2.23 (m)/2.35 (m) 
5 140.7 141.2 - 140.7 141.2 - 
6 122.2 122.9 5.49 (br d, 5.5) 122.3 122.9 5.49 (br d, 5.5) 
7 28.2 28.6 1.85 (m)/2.24 (m) 28.3 28.6 1.84 (m)/2.24 (m) 
8 38.2 38.5 1.76 (m)  38.2 38.5 1.76 (m) 
9 50.0 50.6 1.25 (d, 10.5) 49.9 50.5 1.25 (d, 10.5) 
10 39.4 40.1 - 39.5 40.1 - 
11 71.6 72.1 3.67 (dd, 10.0, 10.5) 71.6 72.1 3.66 (dd, 10.0, 10.5) 
12 80.5 81.0 3.04 (d, 10.0) 80.5 80.9 3.04 (d, 10.0) 
13 54.0 54.7 - 54.1 54.4 - 
14 84.3 85.7 - 84.3 85.7 - 
15 34.1 33.9 1.63 (m)/1.75 (m) 34.1 33.9 1.63 (m)/1.75 (m) 
16 27.1 26.9 1.63 (m)/1.92 (m)  27.1 26.9 1.62 (m)/1.91 (m)  
17 54.7 54.4 2.18 (m) 54.7 54.7 2.17 (m) 
18 11.4 11.0 1.12 (s) 11.5 10.9 1.12 (s) 
19 18.9 19.2 1.19 (s) 19.0 19.2 1.19 (s) 
20 70.4 71.4 3.77 (dq, 6.5, 7.0) 70.5 71.4 3.78 (dq, 6.5, 7.0) 
21 23.5 23.0 1.23 (d, 6.5) 23.7 23.0 1.23 (d, 6.5) 
Cym I       
1 96.3 97.1 4.87 (br d, 10.0) 96.3 97.1 4.87 (dd, 2.0, 9.5) 
2 36.9 36.6 1.57 (m)/2.07 (m) 37.3 36.6 1.58 (m)/2.08 (m) 
3 78.1 78.5 3.86 (m) 78.0 78.6 3.86 (m) 
4 83.8 83.8 3.25 (m) 83.2 83.8 3.24 (m) 
5 69.0 69.9 3.83 (m) 69.0 69.8 3.86 (m) 
6 18.5 18.5 1.20 (d, 6.5) 18.6 18.5 1.21 (d, 6.5) 
3-OMe 58.8 58.5 3.46 (s) 59.0 58.5 3.45 (s) 
Cym II       
1 100.3 101.1 4.80* 100.4 101.1 4.80* 
2 36.9 36.2 1.62 (m)/2.16 (m) 37.1 36.3 1.64 (m)/2.15 (m) 
3 77.8 78.6 3.86 (m) 78.1 78.5 3.86 (m) 
4 83.3 83.9 3.25 (m) 83.4 84.0 3.24 (m) 
5 69.3 70.1 3.87 (m) 69.2 69.9 3.86 (m) 
6 18.5 18.3 1.31 (d, 6.5) 18.5 18.2 1.31 (d, 6.5) 
3-OMe 58.8 58.4 3.45 (s) 58.9 58.5 3.45 (s) 
All       
1 104.1 104.0 4.60 (d, 8.0) 104.0 103.8 4.60 (d, 8.0) 
2 73.1 73.2 3.38 (dd, 3.0, 8.0) 72.5 72.6 3.40 (dd, 3.0, 8.0) 
3 83.2 83.7 3.65 (t, 3.0) 83.0 83.1 3.98 (t, 3.0) 
4 74.4 74.9 3.20 (dd, 3.0, 9.5) 83.0 83.8 3.36 (m) 
5 70.7 70.9 3.69 (m) 68.8 70.0 3.86 (m) 
6 18.5 18.8 1.24 (d, 6.5) 18.3 18.8 1.31 (d, 6.5) 
3-OMe 62.0 62.6 3.62 (s) 61.8 62.0 3.62 (s) 
Glc       
1    106.5 106.1 4.37 (d, 8.0) 
2    75.5 75.4 3.21 (dd, 8.0, 9.0) 
3    78.4 77.9 3.37 (m) 
4    71.9 71.8 3.27 (m) 
5    78.4 77.9 3.31 (m) 
6    63.0 63.0 3.68 (dd, 5.5, 11.5)/3.92 (dd, 2.0, 11.5) 
#δC of dregeoside Da1 in pyridine-d5 [5]; 
$δC of volubiloside A in pyridine-d5 [6]; Cym, β-D-cymaropyranosyl; All, 6-deoxy-3-O-
methyl-β-D-allopyranosyl; Glc, glucopyranosyl; *)Overlapped signals. 
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Table 2. 
1
H- and 
13
C-NMR spectroscopic data for compounds 3 and 4 in CD3OD. 
C  3   4 
δC δH (mult, J in Hz) δC
$ δC δH (mult, J in Hz) 
1 41.4 1.09 (m)/2.67 (m) 40.0 40.4 1.15 (m)/2.67 (m) 
2 30.4 1.66 (m)/1.81 (m) 30.7 30.8 1.57 (m)/1.84 (m) 
3 79.6 3.54 (m) 77.9 79.3 3.50 (m) 
4 40.2 2.31 (m)/2.37 (m) 40.1 40.3 2.20 (m)/2.35 (m) 
5 142.0 - 140.7 141.2 - 
6 118.8 5.34 (t, 3.5) 122.4 122.9 5.48 (d, 5.5) 
7 36.1 1.64 (m)/2.17 (m) 28.4 28.7 1.81(m)/2.29 (m) 
8 76.9 - 37.5 37.8 - 
9 51.6 1.44 (d, 10.5) 49.9 50.5 1.27 (d, 12.0) 
10 40.2 - 39.5 40.1 - 
11 70.8 4.02 (dd, 10.0, 10.5) 71.9 72.3 3.65 (dd, 10.0, 10.5) 
12 82.6 3.17 (d, 10.0) 78.5 78.8 3.07 (d, 9.5) 
13 54.6 - 55.7 56.0 - 
14 86.2 - 84.9 86.0 - 
15 36.0 1.75 (m)/2.15 (m) 35.3 35.4 1.80 (m)/1.99 (m) 
16 27.3 1.62 (m)/1.84 (m) 24.5 24.9 2.00 (m)  
17 56.9 2.08 (m) 58.8 59.0 3.57 (m) 
18 11.5 1.28 (s) 11.0 10.4 0.93 (s) 
19 18.0 1.40 (s) 19.1 19.2 1.18 (s) 
20 70.5 3.75 (dq, 6.5, 7.0) 216.7 218.9 - 
21 22.6 1.20 (d, 6.5) 32.6 32.6 2.26 (s) 
Cym I      
1 97.1 4.89 (dd, 2.0, 9.5) 96.4 97.2 4.87 (dd, 1.5, 9.5) 
2 36.6 1.59 (m)/2.09 (m) 37.3 36.4 1.55 (m)/2.15 (m) 
3 78.6 3.87 (m) 78.2 78.6 3.86 (m) 
4 83.8 3.25 (m) 83.5 83.8 3.24 (m) 
5 69.9 3.83 (m) 69.2 69.9 3.82 (m) 
6 18.5 1.21 (d, 6.5) 18.7 18.5 1.21 (d, 6.5) 
3-OMe 58.5 3.45 (s) 59.2 58.5 3.45 (s) 
Cym II      
1 101.1 4.81* 100.5 101.1 4.81* 
2 36.4 1.65 (m)/2.15(m) 37.5 36.6 1.55(m)/2.07(m) 
3 78.7 3.87 (m) 78.3 78.7 3.86 (m) 
4 84.1 3.25 (m) 83.5 84.1 3.24 (m) 
5 70.0 3.87 (m) 69.4 70.0 3.85 (m) 
6 18.2 1.30 (d, 6.5) 18.4 18.2 1.31 (d, 6.5) 
3-OMe 58.4 3.45 (s) 59.0 58.4 3.45 (s) 
All      
1 103.9 4.60 (d, 8.0) 104.2 103.9 4.60 (d, 8.5) 
2 72.7 3.39 (dd, 3.0, 8.0) 72.7 72.6 3.39 (dd, 3.0, 8.0) 
3 83.2 3.98 (t, 3.0) 83.4 83.2 3.97 (t, 2.0) 
4 83.8 3.36 (m) 83.4 83.8 3.36 (m) 
5 70.1 3.86 (m) 69.4 70.1 3.87 (m) 
6 18.7 1.31 (d, 6.5) 18.7 18.8 1.30 (d, 6.5) 
3-OMe 62.0 3.62 (s) 61.9 62.0 3.62 (s) 
Glc      
1 106.2 4.37 (d, 8.0) 106.7 106.2 4.37 (d, 7.5) 
2 75.5 3.21 (dd, 8.0, 9.0) 75.6 75.5 3.20 (m) 
3 78.0 3.37 (m) 78.5 78.0 3.37 (m) 
4 71.9 3.27 (m) 72.1 71.9 3.26 (m) 
5 78.1 3.31 (m) 78.0 77.9 3.37 (m) 
6 
63.1 3.68 (dd, 6.0, 11.5) 
3.92 (dd, 2.0, 11.5) 
63.2 63.1 3.67 (dd, 6.0, 11.5) 
3.92 (dd, 2.0, 11.5) 
#&δC of volubiloside C in pyridine-d5 [6]; Cym, β-D-cymaropyranosyl; All, 6-deoxy-3-O-methyl-β-D-allopyranosyl; 
 Glc, glucopyranosyl. *)Overlapped signals. 
 
 
Polyhydroxypregnane glycosides from Dregea volubilis 
431 
Compound 1 was isolated as a white amorphous powder. The 
1
H-NMR spectrum of 
compound 1 showed the signals of one olefinic proton [δH 5.49 (1H, br d, J = 5.5 Hz)], one 
secondary methyl group [δH 1.23 (1H, d, J = 6.5 Hz)], and two tertiary methyl groups [δH 1.12 
(3H, s) and 1.20 (3H, s)], suggesting the appearance of a pregnane aglycone; three anomeric 
protons [δH 4.87 (1H, br d, J = 10.0 Hz), 4.80 (overlapped signal), and 4.60 (1H, d, J = 8.0 Hz)], 
two secondary methyl groups [δH 1.20 (1H, d, J = 6.5 Hz), 1.24 (1H, d, J = 6.5 Hz), and 1.31 (d, 
J = 6.5 Hz)], and three methoxy groups [δH 3.45, 3.46, and 3.60 (each 3H, s)] suggesting the 
appearance of three sugar units. 
The 
13
C-NMR and HSQC spectra of compound 1 (Table 1) exhibited the signals of 42 
carbons, including 4 non-protonated carbons, 21 methines, 8 methylenes, and 9 methyl carbons. 
The 
1
H- and 
13
C-NMR data was found to be identical to dregeoside Da1 (1) [5]. The double 
bond at C-5/C-6 was indicated by HMBC (Figure 2) correlations from H-19 (δH 1.19) to C-1 (δC 
40.2)/C-5 (δC 141.2)/C-9 (δC 50.6)/C-10 (δC 40.1). The hydroxyl groups were at C-11, C-12, C-
14, and C-20 was confirmed by the HMBC correlations between H-9 (δH 1.25) and C-11 (δC 
72.1)/C-12 (δC 81.0); H-18 (δH 1.12) and C-12 (δC 81.0)/C-13 (δC 54.7)/C-14 (δC 85.7)/C-17 (δC 
54.4); and between H-21 (δH 1.22) and C-17 (δC 54.4)/C-20 (δC 71.4). The 
13
C-NMR spectra of 
three sugar moieties (δC 97.1, 36.6, 78.5, 83.8, 69.9, 18.5, and 58.5; 101.1, 36.2, 78.6, 83.9, 70.1, 
18.3, and 58.4; 104.0, 73.2, 83.7, 74.9, 70.9, 18.8, and 62.6) as well as multiplicity of anomeric 
protons (δH Cym I: 4.87 (br d, J = 10.0 Hz) and 4.60 (d, J = 8.0 Hz) indicated the sugar moieties 
as β-D-cymaropyranosyl and β-D-allopyranosyl. The HMBC correlations between All H-1 (δH 
4.60) and Cym II C-4 (δC 83.9); Cym II H-1 (δH 4.80) and Cym I C-4 (δC 83.8); and between 
Cym I H-1 (δH 4.87) and C-3 (δC 79.3) determined the sugar linkages as 6-deoxy-3-O-methyl-β-
D-allopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranosyl and at C-3 of 
aglycone. Furthermore, careful examination of J coupling at related protons in 
1
H-NMR spectra 
also supported their relative configurations at C-3, C-11, and C-12. Particularly, signal of H-11 
appeared as double doublet with both large J values (10.5 Hz) indicated both trans axial 
orientations of H-9/H-11 and H-11/H-12. In bio-synthesis partway steroid, H-9 always locates at 
α-axial position. Therefore, the large coupling constant of JH-9/H-11 and JH-11/H-12 indicated β-axial 
position of H-11 and α-axial position of H-12 which were corresponding to α-orientation of 11-
OH and β-orientation of 12-OH. 
Although signal of H-3 appeared as multiplet and made it difficult to calculate J value,  
carbon chemical shift value of C-3 (δC: 79~80 ppm) supported for β-configuration at C-3 [5]. 
Thus, the structure of 1 was identified as dregeoside Da1 [5], and this compound was reported 
from D. volubilis.  
The 
1
H-NMR of 2 showed the signals of one olefinic proton at δH 5.49 (1H, br d, J = 5.5 
Hz), three methyl groups at δH 1.12 (3H, s), 1.19 (3H, s) and 1.23 (3H, d, J = 6.5 Hz) suggesting 
the presence of a pregnane. In addition, the 1H-NMR spectrum also exhibited four anomeric 
protons at δH 4.37 (1H, d, J = 8.0 Hz), 4.60 (1H, d, J = 8.0 Hz), 4.80 (1H, overlapped signal), and 
4.87 (1H, dd, J = 2.0, 9.5 Hz) suggesting the presence of four sugar units. The 
13
C-NMR of 2 
exhibited the signals of 48 carbons, including 21 carbons of pregnane aglycone and 27 carbons 
of sugar units. Analysis of 
1
H- and 
13
C-NMR indicated the structure of 2 was similar to that of 1 
with the addition of a glucopyranosyl unit. The sugar linkage was determined as β-D-
glucopyranosyl-(14)-6-deoxy-3-O-methyl-β-D-allomethylpyranosyl-(1→4)-β-D-
cymaropyranosyl-(1→4)-β-D-cymaropyranoside by HMBC correlations between Glc H-1 (δH 
4.37) and All C-4 (δC 83.8); All H-1 (δH 4.60) and Cym II C-4 (δC 84.0); Cym II H-1 (δH 4.81) 
and Cym I C-4 (δC 83.8). The position of sugar linkage at C-3 of aglycone was confirmed by the 
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HMBC correlation between Cym I H-1 (δH 4.86) and C-3 (δC 78.4). Thus, the structure of 2 was 
defined as volubiloside A [6]. 
Compound 3 was obtained as a white amorphous powder. Analysis of 
1
H- and 
13
C-NMR 
also indicated the structure of 3 to be drevoluoside N [10]. Similar to 2, the sugar linkage was 
determined as β-D-glucopyranosyl-(14)-6-deoxy-3-O-methyl-β-D-allomethylpyranosyl-
(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside by the observation on HMBC 
spectra. The HMBC correlations from H-19 to C-1/C-5/C-9/C-10; from H-6/H-9/H-11 to C-8; 
from H-18 to C-12/C-14/C-17; from H-21 to C-17/C-20 indicated the location of hydroxyl 
groups at C-8, C-11, C-12, C-14, and C-20.. Thus, the structure of 3 was elucidated as 
drevoluoside N. 
The 
1
H-NMR of 4 exhibited one olefinic proton at δH 5.48 (1H, d, J = 5.5 Hz), three methyl 
groups at δH 0.93 (3H, s), 1.18 (3H, s), and 2.26 (3H, s), assigned to a pregame aglycone; four 
anomeric protons at δH 4.37 (1H, d, J = 7.5 Hz), 4.60 (1H, d, J = 8.5 Hz), 4.81 (overlapped), and 
4.87 (1H, dd, J = 1.5, 9.5 Hz). The 
13
C-NMR and HSQC of 4 showed one carbonyl, five non-
protonated carbons, 25 methines, and 9 methyl carbons. The 
1
H- and 
13
C-NMR data of 4 was 
identical to that of volubiloside C [6]. In addition, the position of functional groups was also 
reconfirmed by the analysis of HSQC and HMBC spectra. Thus, the structure of 4 was 
elucidated as volubiloside C.  
 
Figure 2. The key HMBC correlations of compounds 1 – 4. 
Compounds 1-4 were evaluated for their cytotoxic effects on HT-29 cell using MTS assay. 
At concentration of 30 µM, compounds 1-4 did not significantly inhibit HT-29 cell proliferation. 
The percentages of cell viability were obtained to be 101.15 ± 1.50 %, 105.45 ± 1.57 %, 100.83 
± 1.50 %, and 102.86 ± 1.53 % in the presence of compounds 1-4 (30 µM), respectively.   
4. CONCLUSIONS 
The present article reports on phytochemical study of the Dregea volubilis. From the 
methanol extract of the leaves, four polyhydroxypregnane glycosides as dregeoside Da1 (1), 
volubiloside A (2), drevoluoside N (3), and volubiloside C (4) were isolated and structurally 
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elucidated. Their chemical structures were elucidated by 1D, 2D NMR spectra and compared 
with those reported in the literature. At a concentration of 30 µM, all of the compounds 1-4 did 
not show significant cytotoxic activity on HT-29 cells.  
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